Mirum Pharmaceuticals, Inc.

MIRM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001759425

Price chart

Open-market purchases and sales by MIRM insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 15, 20264:10 PM ETSep 14, 2026BJERKHOLT ERICCHIEF FINANCIAL OFFICERSSaleCommon Stock−9.94K$98.37−$978.09K44.75K−18.2%SEC
Sep 3, 20266:54 PM ETSep 2, 2026Howe JolandaSVP, GLOBAL CONTROLLERSSaleCommon Stock−658$100.00−$65.8K616−51.6%SEC10b5-1
Sep 3, 20266:52 PM ETSep 1, 2026Peetz ChristopherCHIEF EXECUTIVE OFFICERSSaleCommon Stock−30K$98.68−$2.96M194.44K−13.4%SEC10b5-1
Aug 19, 20266:19 PM ETAug 18, 2026Howe JolandaSVP, GLOBAL CONTROLLERSSaleCommon Stock−40K$100.00−$4M1.27K−96.9%SEC
Aug 12, 20265:14 PM ETAug 11, 2026BJERKHOLT ERICCHIEF FINANCIAL OFFICERSSaleCommon Stock−6K$99.9016−$599.51K36.36K−14.2%SEC10b5-1

The largest institutional positions in MIRM at the end of Q2 2026.

Institutions holding MIRM in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Frazier Life Sciences Management, L.P.7,679,684$899.06M19.58%00.0%Unchanged
Jupiter Topco LLC5,909,184$691.67M0.28%+5,909,184New
BlackRock, Inc.4,390,063$513.94M0.01%+543,533+14.1%Added
FMR LLC3,670,314$442.3M0.02%+1,704,939+86.7%Added
PRICE T ROWE ASSOCIATES INC /MD/2,655,607$310.89M0.03%+938,186+54.6%Added